India’s Vaccine Hub: 60% of Global Supply Manufactured in Pune

indias-vaccine-success-60-of-global-supply-manufactured-in-pune
Representation image

India has established itself as a global leader in vaccine production, especially after developing Covaxin. The country now manufactures 60% of the world’s vaccines, according to Dr. Balram Bhargava, former Director General of the Indian Council of Medical Research (ICMR).

Keynote Address at RGCB Women’s Day Celebration

As reported by TOI, Dr. Bhargava delivered a keynote address at BRIC-Rajiv Gandhi Centre for Biotechnology (RGCB) on Tuesday. Speaking on the theme ‘Accelerate Action’ as part of RGCB’s Women’s Day celebration, he highlighted India’s contribution to global vaccine supply. “Sixty percent of the world’s vaccines are now manufactured in Pune and distributed worldwide. In 2021, India exported vaccines to more than 100 countries, underscoring our strong research and development capabilities,” he stated.

Seamless Implementation of Vaccine Development

India’s success in vaccine development resulted from well-coordinated efforts in funding, pre-clinical studies, clinical trials, laboratory research, and physiological studies. Dr. Bhargava credited the government’s support for ensuring a smooth process. He also mentioned the formation of a National Task Force consisting of 40 scientists from various research fields who played a crucial role in managing crises.

Also Read |  Childhood BMI Associated with Risk of Skin Diseases

Impact of Vaccination During the Omicron Wave

India recorded the lowest death rate during the Omicron wave compared to countries like Russia, the UK, and the USA. Dr. Bhargava attributed this achievement to the extensive vaccination coverage, with more than 95% of the population immunized. He emphasized how the government and health department worked efficiently to protect citizens during the crisis.

Encouraging Women in Scientific Research

Sharmila Bapat, Director of BRIC-National Centre for Cell Science, Pune, and a pioneer in cancer stem cell research, urged women to take up research in science. She stressed the need for greater female participation in scientific innovation.

Women’s Contributions at RGCB

RGCB Director Chandrabhas Narayana highlighted the significant role played by women faculty and research students at the institute. “One of our faculty members is currently leading the Indian delegation working on cervical cancer eradication. Many of our women students are now pursuing postdoctoral research at prestigious international institutions,” he noted.

Also Read |  Ga-68 NYM046 PET/CT Shows Promise in Diagnosing Primary Tumors in ccRCC Patients

India’s advancements in vaccine production and the increasing participation of women in scientific research continue to shape the nation’s future in healthcare and biotechnology.